Mark Stegall
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients (NCT05220397) | Mark Stegall | 2022-04-11 |
| Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation (NCT01349595) | Mark Stegall | 2011-12-01 |
| Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant (NCT00670774) | Mark Stegall | 2008-03-01 |
Track Mark Stegall automatically
Every clearance here is in the API, with alerts when new ones post.